Sly Saint
Senior Member (Voting Rights)
Chronic diseases like Ehlers-Danlos Syndrome, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), and Fibromyalgia have long been understudied relative to their prevalence and the extent of their disruption of normal life. The emergence of long covid among a significant share of the millions affected by covid-19 adds to the urgency of developing solutions to these debilitating conditions.
Given the high degree of variation from one patient to another and symptoms that can shift over time, patient observation is really the only way to cost-effectively gather the longitudinal data needed to thoroughly understand these conditions. One approach would be to provide patients with tools and training to track their symptoms and response to different therapies on a daily basis over a period of several months. The resulting data could be analyzed using sophisticated qualitative research tools to identify patterns and generate hypotheses for rigorous evaluation of possible treatments using more traditional methods.
This leads to a second, and potentially more controversial suggestion. I would encourage researchers to see patients not just as data collectors, but as partners for generating hypotheses for future evaluation. I readily acknowledge that it will be difficult to separate the wheat from the chaff. But amid a field of theories offered by patients and others, I have seen many well-thought-out hypotheses that merit further scientific investigation.
https://blogs.bmj.com/bmj/2021/09/2...patients-and-caregivers-as-research-partners/